Cannabis Shares Underperform Going Into Year-End Amid U.S. Regulatory Logjam

The Botanicals Podcast

Dec 17 2021 | 00:13:40

00:00 / 00:13:40

Show Notes

Although adult-use sales of cannabis remain robust in U.S. states where it is legal, Nasdaq IR Intelligence analyst Saleem Daya sees continued stock underperformance across the Cannabis space going into year-end, building on activity in the second and third quarters of 2021.

Other Episodes

Episode 1

May 07, 2020 • 00:15:55

JLN checks in with Supercritical on banking relief and a scramble for new canna licenses

In the latest JLN update on the legal cannabis marketplace, Thom Thompson interviews Sparky Rose and Kerry Jordan, principals of the consultancy Supercritical, about...

Episode 0

September 29, 2020 • 00:18:13

Cannabis sector outperforms S&P 500 as U.S. sales grow

Saleem Daya, analyst at Nasdaq corporate solutions in Toronto, updates John Lothian News on the Q2 performance of listed cannabis shares amid strong U.S....

Episode 0

January 12, 2021 • 00:20:25

Cannabis Shares Pick Up Pace As 2021 Regulatory Momentum Eyed

Saleem Daya, an analyst with Nasdaq IR Intelligence in Toronto, sees U.S. cannabis regulation poised for a rehaul in 2021 given Democrats' U.S. Senate...